4.6 Article

Prevention of House Dust Mite Induced Allergic Airways Disease in Mice through Immune Tolerance

Journal

PLOS ONE
Volume 6, Issue 7, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0022320

Keywords

-

Funding

  1. Fundacao para a Ciencia e Tecnologia Portugal [PTDC/SAU-MII/64279/2006, PIC/IC/82895/2007]
  2. Sudoe [Immunonet-SOE1/1P1/E014]
  3. Fundação para a Ciência e a Tecnologia [PIC/IC/82895/2007, PTDC/SAU-MII/64279/2006] Funding Source: FCT

Ask authors/readers for more resources

Allergic airways disease is a consequence of a Th2 response to an allergen leading to a series of manifestations such as production of allergen-specific IgE, inflammatory infiltrates in the airways, and airway hyper-reactivity (AHR). Several strategies have been reported for tolerance induction to allergens leading to protection from allergic airways disease. We now show that CD4 blockade at the time of house dust mite sensitization induces antigen-specific tolerance in mice. Tolerance induction is robust enough to be effective in pre-sensitized animals, even in those where AHR was preestablished. Tolerant mice are protected from airways eosinophilia, Th2 lung infiltration, and AHR. Furthermore, anti-CD4 treated mice remain immune competent to mount immune responses, including Th2, to unrelated antigens. Our findings, therefore, describe a strategy for tolerance induction potentially applicable to other immunogenic proteins besides allergens.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

T follicular cells: The regulators of germinal center homeostasis

Filipa Ribeiro, Esperanza Perucha, Luis Graca

Summary: This article reviews the development and biology of T follicular cell subsets, with a special emphasis on the metabolic regulation of Tfh cells, contributing to a better understanding of GC responses.

IMMUNOLOGY LETTERS (2022)

Article Immunology

The antitumor effect induced by an IL-2 'no-alpha' mutein depends on changes in the CD8+ T lymphocyte/Treg cell balance

Tania Carmenate, Galia Montalvo, Sum Lai Lozada, Yaretnis Rodriguez, Yaquelin Ortiz, Claudia Diaz, Janet Avellanet, Juhee Kim, Charles D. Surh, Luis Graca, Kalet Leon

Summary: High doses of IL-2 have limited efficacy in the treatment of melanoma and renal cell carcinoma, but a small percentage of patients experience complete or long-lasting responses. Expansion of regulatory T cells, specifically ICOS+ highly suppressive Tregs, is associated with worse clinical outcomes. Efforts to improve the cytokine properties of IL-2 are currently under study. A mutein of IL-2 has been developed with higher antitumor activity and less toxicity, and it induces a strong antitumor effect in primary tumor models. The mutein can also change the balance between Tregs and activated CD8(+) memory cells towards immune activation, which explains its efficacy in vivo.

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

Therapeutic targeting of PD-1/PD-L1 blockade by novel small-molecule inhibitors recruits cytotoxic T cells into solid tumor microenvironment

Rita C. Acurcio, Sabina Pozzi, Barbara Carreira, Marta Pojo, Nuria Gomez-Cebrian, Sandra Casimiro, Adelaide Fernandes, Andreia Barateiro, Vitor Farricha, Joaquim Brito, Ana Paula Leandro, Jorge A. R. Salvador, Luis Graca, Leonor Puchades-Carrasco, Luis Costa, Ronit Satchi-Fainaro, Rita C. Guedes, Helena F. Florindo

Summary: This study identifies a new class of small molecule candidates that can regulate the PD-L1/PD-1 signaling pathway, promoting the infiltration of effector CD8 T cells in the tumor microenvironment.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Medicine, General & Internal

Revisiting IgG Antibody Reactivity to Epstein-Barr Virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Its Potential Application to Disease Diagnosis

Nuno Sepulveda, Joao Malato, Franziska Sotzny, Anna D. Grabowska, Andre Fonseca, Clara Cordeiro, Luis Graca, Przemyslaw Biecek, Uta Behrends, Josef Mautner, Francisco Westermeier, Eliana M. Lacerda, Carmen Scheibenbogen

Summary: Infections by Epstein-Barr virus are associated with patients suffering from ME/CFS. This study re-analyzed microarray data and identified two antigens that may serve as biomarkers for disease diagnosis in this patient subgroup. Further research will be conducted to confirm this finding in a separate cohort of patients.

FRONTIERS IN MEDICINE (2022)

Letter Medicine, General & Internal

Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants

Joao Malato, Ruy M. Ribeiro, Pedro P. Leite, Pedro Casaca, Eugenia Fernandes, Carlos Antunes, Valter R. Fonseca, Manuel C. Gomes, Luis Graca

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Multidisciplinary Sciences

Different antibody-associated autoimmune diseases have distinct patterns of T follicular cell dysregulation

Filipa Ribeiro, Vasco C. Romao, Sara Rosa, Katia Jesus, Ana Agua-Doce, Sofia C. Barreira, Patricia Martins, Susana Lopes da Silva, Ema Nobre, Maria Joao Bugalho, Valter R. Fonseca, Joao Eurico Fonseca, Luis Graca

Summary: This study compared circulating Tfr and Tfh subsets in patients with different autoimmune diseases and found that dysregulation of germinal centers (GC) in human autoimmunity is not uniform. Specific patterns of dysregulation may become potential biomarkers for disease and patient stratification.

SCIENTIFIC REPORTS (2022)

Article Medicine, General & Internal

Impact of Misdiagnosis in Case-Control Studies of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Joao Malato, Luis Graca, Nuno Sepulveda

Summary: Misdiagnosis of ME/CFS can be caused by different case definitions or failure to diagnose other diseases, leading to difficulties in reproducing research findings. Simulated data showed that studies with over 500 individuals per group have a minimum power of 80% to detect a genuine association. However, in studies where the potential causal factor is not perfectly determined, such as serological association studies, a minimum power of 80% can only be achieved with over 1000 individuals per group.

DIAGNOSTICS (2023)

Editorial Material Immunology

Illuminating a blind spot in SARS-CoV-2 immunity

Luis Graca, Ana Caetano Faria, Ruy M. Ribeiro

NATURE IMMUNOLOGY (2023)

Editorial Material Immunology

The expanding family of T follicular regulatory cells

Luis Graca, Johanne Jacobsen, Saumya Kumar

SCIENCE IMMUNOLOGY (2023)

Article Biology

Molecular reshaping of phage-displayed Interleukin-2 at beta chain receptor interface to obtain potent super-agonists with improved developability profiles

Gertrudis Rojas, Ernesto Relova-Hernandez, Annia Perez-Riveron, Camila Castro-Martinez, Osmany Diaz-Bravo, Yanelys Cabrera Infante, Tania Gomez, Joaquin Solozabal, Ana Beatriz DiazBravo, Maren Schubert, Marlies Becker, Beatriz Perez-Masson, Dayana Perez-Martinez, Rydell Alvarez-Arzola, Osmany Guirola, Glay Chinea, Luis Graca, Stefan Dubel, Kalet Leon, Tania Carmenate

Summary: Engineered interleukin-2 (IL-2) variants with improved electrostatic complementarity to the IL-2 receptor beta chain and faster association kinetics enhance immune effector responses and anti-tumor effects in vivo. These variants have an accumulation of negatively charged residues at the interface, providing better electrostatic complementarity and faster association kinetics. These findings differentiate them from previously reported superkines.

COMMUNICATIONS BIOLOGY (2023)

Article Multidisciplinary Sciences

Association analysis between symptomology and herpesvirus IgG antibody concentrations in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and multiple sclerosis

Tiago Dias Domingues, Joao Malato, Anna D. Grabowska, Ji-Sook Lee, Jose Ameijeiras-Alonso, Przemyslaw Biecek, Luis Graca, Helena Mourin, Carmen Scheibenbogen, Francisco Westermeier, Luis Nacul, Jacqueline M. Cliff, Eliana Lacerda, Nuno Sepulveda

Summary: In this study, the researchers re-analyzed data from ME/CFS and MS patients and found that IgG antibody data is more informative in explaining the symptoms of MS patients than ME/CFS patients. However, the clinical implications of these findings in ME/CFS patients remain to be determined due to the fluctuating nature of their symptoms.

HELIYON (2023)

Article Chemistry, Multidisciplinary

Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors

Ana I. I. Matos, Carina Peres, Barbara Carreira, Liane I. F. Moura, Rita C. C. Acurcio, Theresa Vogel, Erik Wegener, Filipa Ribeiro, Marta B. B. Afonso, Fabio M. F. Santos, Agueda Martinez-Barriocanal, Diego Arango, Ana S. S. Viana, Pedro M. P. Gois, Liana C. C. Silva, Cecilia M. P. Rodrigues, Luis Graca, Rainer Jordan, Ronit Satchi-Fainaro, Helena F. F. Florindo

Summary: Activation of host immunity by using a POx-PLGA nanovaccine to modulate TAM function and block PD-1, combined with the delivery of peptide antigens, adjuvants, and regulators of TGF-β expression, provides an alternative approach for cancer immunotherapy.

ADVANCED SCIENCE (2023)

Proceedings Paper Computer Science, Information Systems

Impact of Misclassification and Imperfect Serological Tests in Association Analyses of ME/CFS Applied to COVID-19 Data

Joao Malato, Luis Graca, Nuno Sepulveda

Summary: The diagnosis of ME/CFS is problematic due to the lack of a specific biomarker, resulting in uncertainties and potential misdiagnosis. This study investigates the impact of misdiagnosis rates on case-control association studies and extends the analysis to include the possibility of misclassification in a binary factor related to previous exposure. The simulation study focuses on serological testing of SARS-CoV-2 in relation to ME/CFS using data from seroepidemiological studies in Portugal, Spain, and Iran.

RECENT DEVELOPMENTS IN STATISTICS AND DATA SCIENCE, SPE2021 (2022)

Meeting Abstract Biochemistry & Molecular Biology

Multifunctional nanovaccine synergizes with OX40 agonist in triple-negative breast cancer

C. Peres, A. I. Matos, L. I. F. Moura, B. Carreira, M. Verdial, J. Conniot, M. B. Afonso, R. Acurcio, S. Mensurado, L. Graca, R. Satchi-Fainaro, H. Florindo

FEBS OPEN BIO (2022)

Article Clinical Neurology

S100B inhibition protects from chronic experimental autoimmune encephalomyelitis

Catarina Barros, Andreia Barateiro, Alexandre Neto, Beatriz Soromenho, Afonso P. Bastos, Joana M. Mateus, Sara Xapelli, Ana M. Sebastiao, Dora Brites, Luis Graca, Adelaide Fernandes

Summary: Studies have shown a correlation between excessive S100B and demyelination in multiple sclerosis. This research highlights the potential of using S100B-neutralizing small-molecule pentamidine as a therapeutic target to reduce damage and promote recovery in chronic experimental autoimmune encephalomyelitis.

BRAIN COMMUNICATIONS (2022)

No Data Available